KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Total Liabilities (2016 - 2025)

Elevance Health (ELV) has disclosed Total Liabilities for 17 consecutive years, with $78.7 billion as the latest value for Q3 2025.

  • On a quarterly basis, Total Liabilities rose 8.28% to $78.7 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $78.7 billion, a 8.28% increase, with the full-year FY2024 number at $75.5 billion, up 8.54% from a year prior.
  • Total Liabilities was $78.7 billion for Q3 2025 at Elevance Health, up from $78.1 billion in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $78.7 billion in Q3 2025 to a low of $61.1 billion in Q2 2021.
  • A 5-year average of $69.3 billion and a median of $70.7 billion in 2024 define the central range for Total Liabilities.
  • Peak YoY movement for Total Liabilities: grew 21.81% in 2021, then fell 0.55% in 2024.
  • Elevance Health's Total Liabilities stood at $61.3 billion in 2021, then increased by 8.3% to $66.4 billion in 2022, then rose by 4.66% to $69.5 billion in 2023, then rose by 8.54% to $75.5 billion in 2024, then rose by 4.25% to $78.7 billion in 2025.
  • Per Business Quant, the three most recent readings for ELV's Total Liabilities are $78.7 billion (Q3 2025), $78.1 billion (Q2 2025), and $77.1 billion (Q1 2025).